Yang Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yang Peng has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Zhen Li
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
9 shared publications - Gordon Brent Mills
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
6 shared publications - Guang Peng
Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
6 shared publications - Ie-Ming Shih
Departments of Obstetrics and Gynecology, Oncology, and Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
6 shared publications - Ivan P. Uray
Faculty of Medicine, Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary.
6 shared publications - Jianfeng Shen
Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
6 shared publications
Latest Publications
- Open Access
- 22 March 2025
- Published by Springer Nature in European Radiology Experimental
- Vol. 9 (1) , 1-12
MRI radiomic study on prediction of nonenlarged lymph node metastasis of rectal cancer: reduced field-of-view versus conventional DWI
Background: Nonenlarged lymph node metastasis (NELNM) of rectal cancer is easily overlooked because these apparently normal lymph nodes are sometimes too small to measure directly using imaging techniques. Radiomic-based multiparametric imaging sequences could predict NELNM based on the primary lesion of rectal cancer. We aimed to study the performance of magnetic resonance imaging (MRI) radiomics derived from reduced field-of-view diffusion-weighted imaging (rDWI) and conventional DWI (cDWI) for the prediction of NELNM. Methods: A total of 86 rectal cancer patients (60 and 26 patients in training and test cohorts, respectively), underwent multiparametric MRI. Radiomic features were extracted from the whole primary lesion of rectal cancer segmented on T2-weighted imaging (T2WI), rDWI, and cDWI, both with b-value of 800 s/mm2 and apparent diffusion coefficient (ADC) maps from both DWI sequences (rADC and cADC). The radiomic models based on the above imaging methods were built for the assessment of NELNM status. Their diagnostic performances were evaluated in comparison with subjective evaluation by radiologists. Results: rADC demonstrated a significant advantage over subjective assessment in predicting NELNM in both training and test cohorts (p ≤ 0.002). In the test cohort, rADC exhibited a significantly higher area under the receiver operating characteristics curve than cADC, cDWIb800, and T2WI (p ≤ 0.020) in assessing NELNM for region-of-interest (ROI) delineation while excelling over rDWIb800 for prediction of NELNM (p = 0.0498). Conclusion: Radiomic features based on rADC outperformed those derived from T2WI and fDWI in predicting the NELNM status of rectal cancer, rADC was more advantageous than rDWIb800 in assessing NELNM. Relevance statement: Advanced rDWI excelled over cDWI in radiomic assessment of NELNM of rectal cancer, with the best performance observed for rADC, in contrast to rDWIb800, cADC, cDWIb800, and T2WI. Key Points: rDWI, cDWI, and T2WI radiomics could help assess NELNM of rectal cancer. Radiomic features based on rADC outperformed those based on rDWIb800, cADC, cDWIb800, and T2WI in predicting NELNM. For rDWI radiomics, the ADC map was more accurate and reliable than DWI to assess NELNM for region of interest delineation. Graphical
- 22 March 2025
- Published by Springer Nature in European Radiology Experimental
- Vol. 9 (1) , 1-12
Open AccessMRI radiomic study on prediction of nonenlarged lymph node metastasis of rectal cancer: reduced field-of-view versus conventional DWI
Background: Nonenlarged lymph node metastasis (NELNM) of rectal cancer is easily overlooked because these apparently normal lymph nodes are sometimes too small to measure directly using imaging techniques. Radiomic-based multiparametric imaging sequences could predict NELNM based on the primary lesion of rectal cancer. We aimed to study the performance of magnetic resonance imaging (MRI) radiomics derived from reduced field-of-view diffusion-weighted imaging (rDWI) and conventional DWI (cDWI) for the prediction of NELNM. Methods: A total of 86 rectal cancer patients (60 and 26 patients in training and test cohorts, respectively), underwent multiparametric MRI. Radiomic features were extracted from the whole primary lesion of rectal cancer segmented on T2-weighted imaging (T2WI), rDWI, and cDWI, both with b-value of 800 s/mm2 and apparent diffusion coefficient (ADC) maps from both DWI sequences (rADC and cADC). The radiomic models based on the above imaging methods were built for the assessment of NELNM status. Their diagnostic performances were evaluated in comparison with subjective evaluation by radiologists. Results: rADC demonstrated a significant advantage over subjective assessment in predicting NELNM in both training and test cohorts (p ≤ 0.002). In the test cohort, rADC exhibited a significantly higher area under the receiver operating characteristics curve than cADC, cDWIb800, and T2WI (p ≤ 0.020) in assessing NELNM for region-of-interest (ROI) delineation while excelling over rDWIb800 for prediction of NELNM (p = 0.0498). Conclusion: Radiomic features based on rADC outperformed those derived from T2WI and fDWI in predicting the NELNM status of rectal cancer, rADC was more advantageous than rDWIb800 in assessing NELNM. Relevance statement: Advanced rDWI excelled over cDWI in radiomic assessment of NELNM of rectal cancer, with the best performance observed for rADC, in contrast to rDWIb800, cADC, cDWIb800, and T2WI. Key Points: rDWI, cDWI, and T2WI radiomics could help assess NELNM of rectal cancer. Radiomic features based on rADC outperformed those based on rDWIb800, cADC, cDWIb800, and T2WI in predicting NELNM. For rDWI radiomics, the ADC map was more accurate and reliable than DWI to assess NELNM for region of interest delineation. Graphical
- Open Access
- 1 February 2025
- Published by Tsinghua University Press in Journal of Advanced Ceramics
- Vol. 14 (2)
Unique composite architecture of phosphor-in-glass film coated on different heat-conducting substrates for high-brightness laser lighting
Next-generation high-brightness laser lighting confronts a key challenge in developing static luminescent materials with remarkable optical-thermal performances and low cost. Herein, a unique composite architecture of Y3Al5O12:Ce3+ (YAG) phosphor-in-glass film coated on different heat-conducting substrates (PiGF@HCSs), i.e., PiGF@sapphire, PiGF@Al2O3, PiGF@AlN, and PiGF@BN-AlN composites, was designed and prepared by a simple film printing and low-temperature sintering technology. The heat-conducting substrates significantly affect the luminescence saturation and phosphor conversion of PiGF@HCSs, making the substrates with higher thermal conductivity (TC) can bear higher laser power density (LPD) and higher reflectivity can enable higher luminous efficacy (LE). As a consequence, the PiGF@sapphire realizes a luminous flux (LF) of 2076 lm@12 W/mm2, which is higher than the PiGF@Al2O3 of 1890 lm@15 W/mm2 and the PiGF@AlN of 1915 lm@24 W/mm2, while the PiGF@BN-AlN enables a maximum LF of 3058 lm@21 W/mm2. Furthermore, the LE of PiGF@BN-AlN reaches up to 194 lm/W, which is 1.6 times that of PiGF@AlN, while that of PiGF@sapphire and PiGF@Al2O3 are 192 lm/W and 150 lm/W, respectively. The working temperature of PiGF@AlN is only 93.3℃ under the LPD of 9 W/mm2, while that of PiGF@sapphire, PiGF@Al2O3, and PiGF@BN-AlN rises to 193.8℃, 133.6℃, and 117℃, respectively. These findings will provide the guiding idea for the commercial applications of PiGF@HCS converters in high-brightness laser lighting and display.
- 1 February 2025
- Published by Tsinghua University Press in Journal of Advanced Ceramics
- Vol. 14 (2)
Open AccessUnique composite architecture of phosphor-in-glass film coated on different heat-conducting substrates for high-brightness laser lighting
Next-generation high-brightness laser lighting confronts a key challenge in developing static luminescent materials with remarkable optical-thermal performances and low cost. Herein, a unique composite architecture of Y3Al5O12:Ce3+ (YAG) phosphor-in-glass film coated on different heat-conducting substrates (PiGF@HCSs), i.e., PiGF@sapphire, PiGF@Al2O3, PiGF@AlN, and PiGF@BN-AlN composites, was designed and prepared by a simple film printing and low-temperature sintering technology. The heat-conducting substrates significantly affect the luminescence saturation and phosphor conversion of PiGF@HCSs, making the substrates with higher thermal conductivity (TC) can bear higher laser power density (LPD) and higher reflectivity can enable higher luminous efficacy (LE). As a consequence, the PiGF@sapphire realizes a luminous flux (LF) of 2076 lm@12 W/mm2, which is higher than the PiGF@Al2O3 of 1890 lm@15 W/mm2 and the PiGF@AlN of 1915 lm@24 W/mm2, while the PiGF@BN-AlN enables a maximum LF of 3058 lm@21 W/mm2. Furthermore, the LE of PiGF@BN-AlN reaches up to 194 lm/W, which is 1.6 times that of PiGF@AlN, while that of PiGF@sapphire and PiGF@Al2O3 are 192 lm/W and 150 lm/W, respectively. The working temperature of PiGF@AlN is only 93.3℃ under the LPD of 9 W/mm2, while that of PiGF@sapphire, PiGF@Al2O3, and PiGF@BN-AlN rises to 193.8℃, 133.6℃, and 117℃, respectively. These findings will provide the guiding idea for the commercial applications of PiGF@HCS converters in high-brightness laser lighting and display.
- 7 May 2024
- Published by Wiley in NMR in Biomedicine
- Vol. 37 (10) , e5174
R2* mapping and reduced field‐of‐view diffusion‐weighted imaging for preoperative assessment of nonenlarged lymph node metastasis in rectal cancer
The aim of the current study is to investigate the diagnostic value of R2* mapping versus reduced field‐of‐view diffusion‐weighted imaging (rDWI) of the primary lesion of rectal cancer for preoperative prediction of nonenlarged lymph node metastasis (NLNM). Eighty‐one patients with pathologically confirmed rectal cancer underwent preoperative R2* mapping and rDWI sequences before total mesorectal excisions and accompanying regional lymph node dissections. Two radiologists independently performed whole‐tumor measurements of R2* and apparent diffusion coefficient (ADC) parameters on primary lesions of rectal cancer. Patients were divided into positive (NLNM+) and negative (NLNM‐) groups based on their pathological analysis. The tumor location, maximum diameter of the tumor, and maximum short diameter of the lymph node were assessed. R2* and ADC, pT stage, tumor grade, status of mesorectal fascia, and extramural vascular invasion were also studied for their potential relationships with NLNM using multivariate logistic regression analysis. The NLNM+ group had significantly higher R2* (43.56 ± 8.43 vs. 33.87 ± 9.57, p < 0.001) and lower ADC (1.00 ± 0.13 vs. 1.06 ± 0.22, p = 0.036) than the NLNM‐ group. R2* and ADC were correlated to lymph node metastasis (r = 0.510, p < 0.001 for R2*; r = −0.235, p = 0.035 for ADC). R2* and ADC showed good and moderate diagnostic abilities in the assessment of NLNM status with corresponding area‐under‐the‐curve values of 0.795 and 0.636. R2* provided a significantly better diagnostic performance compared with ADC for the prediction of NLNM status (z = 1.962, p = 0.0498). The multivariate logistic regression analysis demonstrated that R2* was a compelling factor of lymph node metastasis (odds ratio = 56.485, 95% confidence interval: 5.759–554.013; p = 0.001). R2* mapping had significantly higher diagnostic performance than rDWI from the primary tumor of rectal cancer in the prediction of NLNM status.
- 7 May 2024
- Published by Wiley in NMR in Biomedicine
- Vol. 37 (10) , e5174
R2* mapping and reduced field‐of‐view diffusion‐weighted imaging for preoperative assessment of nonenlarged lymph node metastasis in rectal cancer
The aim of the current study is to investigate the diagnostic value of R2* mapping versus reduced field‐of‐view diffusion‐weighted imaging (rDWI) of the primary lesion of rectal cancer for preoperative prediction of nonenlarged lymph node metastasis (NLNM). Eighty‐one patients with pathologically confirmed rectal cancer underwent preoperative R2* mapping and rDWI sequences before total mesorectal excisions and accompanying regional lymph node dissections. Two radiologists independently performed whole‐tumor measurements of R2* and apparent diffusion coefficient (ADC) parameters on primary lesions of rectal cancer. Patients were divided into positive (NLNM+) and negative (NLNM‐) groups based on their pathological analysis. The tumor location, maximum diameter of the tumor, and maximum short diameter of the lymph node were assessed. R2* and ADC, pT stage, tumor grade, status of mesorectal fascia, and extramural vascular invasion were also studied for their potential relationships with NLNM using multivariate logistic regression analysis. The NLNM+ group had significantly higher R2* (43.56 ± 8.43 vs. 33.87 ± 9.57, p < 0.001) and lower ADC (1.00 ± 0.13 vs. 1.06 ± 0.22, p = 0.036) than the NLNM‐ group. R2* and ADC were correlated to lymph node metastasis (r = 0.510, p < 0.001 for R2*; r = −0.235, p = 0.035 for ADC). R2* and ADC showed good and moderate diagnostic abilities in the assessment of NLNM status with corresponding area‐under‐the‐curve values of 0.795 and 0.636. R2* provided a significantly better diagnostic performance compared with ADC for the prediction of NLNM status (z = 1.962, p = 0.0498). The multivariate logistic regression analysis demonstrated that R2* was a compelling factor of lymph node metastasis (odds ratio = 56.485, 95% confidence interval: 5.759–554.013; p = 0.001). R2* mapping had significantly higher diagnostic performance than rDWI from the primary tumor of rectal cancer in the prediction of NLNM status.
- Open Access
- 14 June 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 720
Chemical Shift-Encoded Sequence (IDEAL-IQ) and Amide Proton Transfer (APT) MRI for Prediction of Histopathological Factors of Rectal Cancer
To investigate whether parameters from IDEAL-IQ/amide proton transfer MRI (APTWI) could help predict histopathological factors of rectal cancer. Preoperative IDEAL-IQ and APTWI sequences of 67 patients with rectal cancer were retrospectively analyzed. The intra-tumoral proton density fat fraction (PDFF), R2* and magnetization transfer ratio asymmetry (MTRasym (3.5 ppm)) were measured according to the histopathological factors of rectal cancer. The relationship between MR parameters and histopathological factors were analyzed, along with diagnostic performance of MR parameters. PDFF, R2* and MTRasym (3.5 ppm) were statistically different between T1+T2/T3+T4 stages, non-metastatic/metastatic lymph nodes, lower/higher tumor grade and negative/positive status of MRF and EMVI (p < 0.001 for PDFF, p = 0.000–0.015 for R2* and p = 0.000–0.006 for MTRasym (3.5 ppm)). There were positive correlations between the above parameters and the histopathological features of rectal cancer (r = 0.464–0.723 for PDFF (p < 0.001), 0.299–0.651 for R2* (p = 0.000–0.014), and 0.337–0.667 for MTRasym (3.5 ppm) (p = 0.000–0.005)). MTRasym (3.5 ppm) correlated moderately and mildly with PDFF (r = 0.563, p < 0.001) and R2* (r = 0.335, p = 0.006), respectively. PDFF provided a significantly higher diagnostic ability than MTRasym (3.5 ppm) for distinguishing metastatic from non-metastatic lymph nodes (z = 2.407, p = 0.0161). No significant differences were found in MR parameters for distinguishing other histopathological features (p > 0.05). IDEAL-IQ and APTWI were associated with histopathological factors of rectal cancer, and might serve as non-invasive biomarkers for characterizing rectal cancer.
- 14 June 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (6) , 720
Open AccessChemical Shift-Encoded Sequence (IDEAL-IQ) and Amide Proton Transfer (APT) MRI for Prediction of Histopathological Factors of Rectal Cancer
To investigate whether parameters from IDEAL-IQ/amide proton transfer MRI (APTWI) could help predict histopathological factors of rectal cancer. Preoperative IDEAL-IQ and APTWI sequences of 67 patients with rectal cancer were retrospectively analyzed. The intra-tumoral proton density fat fraction (PDFF), R2* and magnetization transfer ratio asymmetry (MTRasym (3.5 ppm)) were measured according to the histopathological factors of rectal cancer. The relationship between MR parameters and histopathological factors were analyzed, along with diagnostic performance of MR parameters. PDFF, R2* and MTRasym (3.5 ppm) were statistically different between T1+T2/T3+T4 stages, non-metastatic/metastatic lymph nodes, lower/higher tumor grade and negative/positive status of MRF and EMVI (p < 0.001 for PDFF, p = 0.000–0.015 for R2* and p = 0.000–0.006 for MTRasym (3.5 ppm)). There were positive correlations between the above parameters and the histopathological features of rectal cancer (r = 0.464–0.723 for PDFF (p < 0.001), 0.299–0.651 for R2* (p = 0.000–0.014), and 0.337–0.667 for MTRasym (3.5 ppm) (p = 0.000–0.005)). MTRasym (3.5 ppm) correlated moderately and mildly with PDFF (r = 0.563, p < 0.001) and R2* (r = 0.335, p = 0.006), respectively. PDFF provided a significantly higher diagnostic ability than MTRasym (3.5 ppm) for distinguishing metastatic from non-metastatic lymph nodes (z = 2.407, p = 0.0161). No significant differences were found in MR parameters for distinguishing other histopathological features (p > 0.05). IDEAL-IQ and APTWI were associated with histopathological factors of rectal cancer, and might serve as non-invasive biomarkers for characterizing rectal cancer.
- Open Access
- 1 May 2023
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 13 (5) , 3199-3212
Assessing the histopathological features of rectal adenocarcinoma with chemical shift–encoded sequence (CSE)-MRI and diffusion-weighted imaging (DWI)
Original Article Assessing the histopathological features of rectal adenocarcinoma with chemical shift–encoded sequence (CSE)-MRI and diffusion- weighted imaging (DWI) Yang Peng, Jiali Li, Xuemei Hu, Yaqi Shen, Daoyu Hu, Zhen Li, Ihab Kamel
- 1 May 2023
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 13 (5) , 3199-3212
Open AccessAssessing the histopathological features of rectal adenocarcinoma with chemical shift–encoded sequence (CSE)-MRI and diffusion-weighted imaging (DWI)
Original Article Assessing the histopathological features of rectal adenocarcinoma with chemical shift–encoded sequence (CSE)-MRI and diffusion- weighted imaging (DWI) Yang Peng, Jiali Li, Xuemei Hu, Yaqi Shen, Daoyu Hu, Zhen Li, Ihab Kamel
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Supplementary Methods from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Supplementary Methods from ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors